CannabisNewsBreaks – GB Sciences, Inc. (GBLX) Sells 50% Ownership Stake in GB Sciences Louisiana, LLC

GB Sciences (OTCQB: GBLX) today announced that it has filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana, LLC. for $16 million. The stake will be bought by Wellcana Plus at a fee of $7 million in cash at closing, $1 million in cash within 60 days of closing, and the remaining $8 million as an earn out. The profitability of the Louisiana operations will determine the proceeds realized through the earn out as well as the timing of those proceeds. The sale enables GBLX to focus on attaining a DEA license, profitability and GMP-compliancy at its Las Vegas, Nevada location. The company plans to collaborate with GB Sciences Louisiana on research and clinical trial opportunities in the future. Upon reaching mutually agreeable terms, GBLX will license its proprietary formulations to GB Sciences Louisiana for use in its research and final formulations.

To view the full press release, visit http://cnw.fm/skM8z

About GB Sciences, Inc.

GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. For more information, visit the company’s website at www.GBSciences.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) Appoints Consumer Products and Healthcare Industry Veteran Peter Vitulli to its Board

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) this morning announced its appointment of Peter Vitulli to its board of directors. According to the update, Vitulli currently serves as an operating advisor at Windrose Health Investors and has extensive experience spanning 35 years in the consumer products and healthcare industries with both large corporations and entrepreneurial start-ups. Earlier in his career, Peter was president and general manager of the $1 billion North American Gatorade business. He most recently served as president and CEO of DNA Diagnostics Center, one of the world’s largest providers of private DNA tests. “I have a long-standing relationship with Peter and look forward to having him on our board,” TransCanna President and CEO Steve Giblin said in the news release. “His related experience growing companies and specifically in the medical diagnostic area will help fast track critical decisions to build out our management team and introduce new products.”

To view the full press release, visit http://cnw.fm/I8zmN

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://cnw.fm/TCAN

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Willow Biosciences Inc. (CSE: WLLW) today announced its plans to participate at the Eight Capital & Cassels Brock Global Cannabis Conference slated to be held at the Shangri-La Hotel in Toronto on September 19, 2019. Willow Biosciences will be available for one-on-one meetings during the event. In addition, Willow CEO, President and Director Trevor Peters will present in the panel, “Pushing the Boundaries Through Technology, Innovation & Research,” at 10:30 a.m. Eastern Time in the Queen’s Park Ballroom.

To view the full press release, visit http://cnw.fm/LS4j3

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Partners with John Legend and Casper in Nationwide Launch of 100% Hemp CBD Product Line

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in California, this morning announced the nationwide launch of its first-ever 100% hemp CBD product line. According to the update, a newly established brand partnership between PLUS and American superstar and philanthropist John Legend supports the launch, and Legend will advocate on behalf of the company’s new nationwide hemp CBD product offering. “I have been a believer in the benefits of CBD for some time,” stated Legend. “I was drawn to the PLUS team because they’re an innovative, family-run company, and they use science to deliver a consistent, high-quality product. I appreciate that they’re committed to setting a high standard within an industry that has to date been fairly unregulated.”

In addition, Plus Products is partnering with global, award-winning company Casper Sleep Inc. to introduce its melatonin- and CBD-infused SLEEP product. “We’re always exploring new ways to improve sleep across the entire sleep arc — from sunset to sunrise,” Neil Parikh, co-founder and chief strategy officer at Casper, said in the news release. “Like PLUS, we believe sleep is a key part of the wellness equation. Partnering with their team of experts to introduce CBD sleep gummies brings a new way to relax and rest to those who need it.”

To view the full press release, visit http://cnw.fm/6epVb

About Plus Products Inc.

PLUS Products is a California-based edibles company focused on using nature to bring balance to consumers’ lives. PLUS is headquartered in San Mateo, CA with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLPRF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has engaged with Linneo Health S.L., a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. A European leader in the pharmaceutical cannabis industry, Linneo Health recently received its EU-GMP (“Good Manufacturing Practices”) certification from the Spanish regulatory authorities. According to the update, the multi-year agreement includes increasing supply volumes as VIVO expands in the European medical market. “Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth,” VIVO CEO Barry Fishman said in the news release. “We are excited to have an EU-GMP certified source of medical cannabis located within Europe. Through this partnership, we expect to be able to supply the European high-growth market with premium medical cannabis products and services. Our European based supply will allow VIVO to contribute to addressing the unmet medical needs of patients in Germany, which is one of our key target markets for international expansion.”

To view the full press release, visit http://cnw.fm/GyH9P

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Enters Distribution Agreement to Launch Medical Cannabis Inhaler in Canada

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company Syqe Medical, Ltd. to launch Syqe’s flagship product, the Syqe(TM) Inhaler, in Canada. The Syqe Inhaler is a metered-dose medical cannabis inhaler that provides quick pain relief while decreasing psychoactive effects and enabling patients to go about their normal daily activities. The inhaler’s use of metered dosing allows patients and healthcare providers to consistently deliver treatment at pharmaceutical standards. Through its wholly owned subsidiaries, TerrAscend Canada and Solace Health Network, TerrAscend will undertake marketing, distribution, and sales efforts of the Syqe Inhaler. “We continue to be thrilled with the steps TerrAscend is taking to build an industry-leading business that spans retail, manufacturing, distribution, biotechnology, and now health tech,” Canopy Rivers president and CEO Narbe Alexandrian stated in the news release. “We believe that TerrAscend is uniquely positioned in the Canadian market to deliver on the consumer demand for innovative and rigorously tested products like the Syqe device.”

To view the full press release, visit http://cnw.fm/9g2Ht

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human CBD Study Results Published in Peer Reviewed Clinical Journal

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced the publication of final study results of the 2018 human clinical study evaluating CBD delivery and effectiveness using its patented DehydraTECH(TM) powered TurboCBD(TM); capsules. According to the update results were published in the peer reviewed medical journal, Advances in Therapy, which focuses on clinical medicine and pharmaceutical research and has been published continually since 1984. Lexaria reported several key findings highlighted in the publication, including but not limited to: CBD in-plasma levels with the 90mg dose of TurboCBD were significantly higher than with the generic 90 mg dose at both 90 and 120 minutes; and only the 90 mg dose of TurboCBD was elevated (i.e., greater than the placebo) at 30 minutes and remained elevated at 4 hours.

To view the full press releases, visit http://cnw.fm/oKfH6

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Mexican Senate to Start Debating Cannabis Legalization This Week

The Senate in Mexico is set to start debating the legalization of marijuana this week, according to information from the leader of the Morena Party.

Different Senate committees will consider the different proposals before them before a bill is put together, possibly by the end of October.

Jesusa Rodriguez Martinez, a Senator belonging to the Morena Party, revealed that there are thirteen legalization proposals before the upper chamber of the Mexico legislature. These proposals will all be discussed during open committee sessions.

During those sessions, members of the public and other stakeholders will be invited to share their views on those proposals.

Early this year, the Supreme Court of Mexico made a landmark ruling that it was unconstitutional for the government to prohibit the recreational use of marijuana by adults. That latest ruling was the fifth such ruling, and under Mexican law, once the Supreme Court makes five similar rulings on a matter, then all other courts are obliged to rule in the same way if a similar matter is brought before them.

It should be remembered that the Supreme Court also gave the government a deadline within which the appropriate law should be drafted and passed. The clock is ticking on that deadline so the lawmakers have to act fast to avoid missing the court-imposed deadline.

During a summit held at the Senate to kick start discussions on marijuana legalization, a former U.S. narcotics official, Gil Kerlikowske, addressed the summit. He urged the lawmakers to pass what he called “robust regulation” to keep minors from accessing recreational cannabis.

He referred to research that suggests that marijuana can be harmful to the developing brains of young people. Strict regulation is required to prevent such harm, he argued.

He also added that there should be strict rules governing the production, packaging and marketing of recreational marijuana once it becomes legal. Kerlikowske also recommended that the country taxes recreational marijuana and the tax revenue should be directed towards marijuana law enforcement efforts, drug prevention and rehabilitation of those suffering from drug use disorders.

In an indirect criticism of the U.S. states that have legalized recreational marijuana, Kerlikowske said that they had all failed to stamp out the black market and yet eliminating the black market is vital to controlling recreational marijuana in any jurisdiction.

It remains to be seen what form the Mexican legalization law will take. Analysts think industry actors like Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) are confident that the Mexicans have done their research and will pass a law that is good for all stakeholders, such as law enforcement and consumers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Congress to Vote on Marijuana Banking Bill This Month

A bipartisan bill that was drafted to protect the banks that accept marijuana businesses as clients will be put before the whole House for a vote this month, according to the office of the Majority Leader.

This decision was announced during a closed-door meeting of the Democratic Party lawmakers held on Thursday. The exact date hasn’t been agreed upon, but it will be this month.

Some lawmakers who attended that closed-door meeting revealed that there was a suggestion that the bill be voted upon after suspending the rules of procedure. If this were to happen, at least two-thirds of the lawmakers have to vote in favor of the bill if it is to pass.

The SAFE Banking Act currently has 206 cosponsors, which means that the advocates of this bill still have some work to convince more members to come on board so that the option of voting under suspended rules can result in success.

The suspension process also doesn’t allow lawmakers to make any changes to the law being considered, and this could be a potential flashpoint since it is possible that some legislators want to include other provisions, such as protecting banks that do business with hemp companies, before the bill is passed.

It isn’t entirely far-fetched to consider the possibility that a completely new bill may be tabled for a vote. This option is likely in case the lawmakers talked to those who are opposed to the SAFE Banking Act and new terms were agreed upon and included in the new version. This could explain why the idea of voting under suspended rules arises.

The SAFE Banking Act had been expected to receive a floor vote before the House went on recess in August, but this didn’t happen.

Meanwhile, the Senate Banking Committee is also getting set to vote on a marijuana banking bill. No date has been set, but committee chair Mike Crapo (R-ID) said on Thursday that a panel is getting the bill ready.

This announcement may have forced the hand of the Democrats in Congress since they have been unwilling to let the Republicans in Senate advance the marijuana law before the Democrats do anything along the same lines.

The Democrats have positioned themselves as the champions of marijuana law reform, so it is crucial, at least for perception purposes, for the bill in Congress to be voted upon before the Republican-dominated Senate considers a similar bill.

Regardless of the motives behind the timing of the House vote, analysts believe different members of the marijuana industry, such as The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF), will welcome this crucial legislation since it will make it easier for the industry to thrive.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Benzinga Announces Initial Lineup For Cannabis Capital Conference in Chicago: Charlie Bachtell, Axel Bernabe, Hadley Ford Among Speakers

Benzinga, a leading financial media outlet, is announcing the first round of speakers for the fifth iteration of the Cannabis Capital Conference in Chicago, Oct. 22-23.

Following the historical format of the renowned conference, day one of the event brings top cannabis executives, multistate operators, leading investors, pioneers in the pharmaceutical space and more in front of attendees. Topics will touch on extremely relevant advancements in Chicago, following the imminent regulation, as well as news on the U.S. market and beyond.

Exclusive keynote speakers include Cresco Labs CEO Charlie Bachtell and New Frontier Data COO Gary Allen. Intimate fireside chats will cover topics surrounding the developments of multi-state operators, listing on different markets, brand expansion and more.

Jessica Billingsley, CEO of Akerna will speak with Jay Heller, Head of Capital Markets of NASDAQ to discuss going public, performing on the market and more. To deep-dive into the Colorado market, Benzinga will present Dave Martyn, President of Starbuds and Andy Williams, CEO and co-founder of Medicine Man to discuss opportunities and growth.

Additionally, Axel Bernabe, the Assistant Counsel to Governor Andrew Cuomo, will educate about the development and implementation of all legal and policy initiatives related to medical, hemp, and adult-use cannabis for New York.

Other notable panels include a discussion on brand distribution from some of the most important companies in the industry, an MSO panel, an inside look into the science behind cannabis extraction and an overview of cannabis consolidation.

Contact Hannah Genig at 734-752-9271 or hannahgenig@benzinga.com for interviews, photos, press credentials or any questions regarding media coverage.

About the Conference

The Benzinga Cannabis Capital Conference is the premier gathering of cannabis entrepreneurs and investors in North America. No other conference offers the level of access and seamlessness of interaction between entrepreneurs building future billion-dollar cannabis enterprises and the investors whose capital will make that happen.

These elite events offer entrepreneurs and investors the once-in-a-lifetime opportunity to network, make deals and learn from influencers, policymakers and trailblazers. Benzinga is the go-to source for investors who need the latest news in the cannabis sector, and frequently breaks exclusive coverage on celebrity cannabis entrepreneurs and commentary from leading political and business figures.

Tickets for the event are on-sale and going fast. Entrepreneurs and those interested in investing in cannabis can purchase tickets here.